Clinical TrialsSearch results
Number of results: 323
Other
- Assessment of health-related quality of life in Japanese patients with chronic hepatitis C
- chronic hepatitis C
- Gunma Liver Study Group
- 2014-05-01
Other
- Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral road
- chronic hepatitis C
- Gunma Liver Study Group
- 2014-05-01
Other
- Randomized controlled trial of 72-week Peg-IFN alpha-2b/ribavirin therapy with or without EPL (polyenephosphatidylcholine) for chronic hepatitis C patients with genotype 1b and high viral load
- Chronic hepatitis C with serotype 1 and high viral load
- Gunma Liver Study Group
- 2014-03-01
Other
- A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administration
- chronic hepatitis B
- Gunma Liver Study Group
- 2014-01-01
Other
- Growth hormone replacement therapy for NASH patients due to adult pituitary gland hyposecretion
- Non Alcoholic steatohepatitis
- Gunma Liver Study Group
- 2013-12-31
Other
- A open-label study of Entecavir in the patients with acute hepatitis B for preventing chronicity and aggravation
- Acute hepatitis B
- Gunma Liver Study Group
- 2013-10-01
Other
- Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.
- encapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)
- Division of Nephrology, Department of Medicine, Jichi Medical University
- 2013-04-30
Other
- Treatment efficacy of pegintron alpha-2b and rivavirin for chronic hepatitis C patients with genotype 2 and high viral loads based on the dissapearance speed of serum HCV-RNA
- chronic hepatitis C with genotype 2 and high viral loads
- Gunma Liver Study Group (GLSG)
- 2012-12-31
Other
- Entecavir for the treatment of breakthrough hepatitis caused by lamivudine and adefovir dipivoxil-resistant mutants of hepatitis B virus
- chronic hepaittis B
- Gunma Liver Study Group (GLSG)
- 2012-10-01
Other
- Tenofovir for the treatment of breakthrough hepatitis caused by lamivudine and adefovir dipivoxil-resistant mutants of hepatitis B virus
- chronic hepatitis B
- Gunma Liver Study Group (GLSG)
- 2012-10-01